DCs as cancer vaccines. Mature DCs as a tool to sustain minimal residual disease status in malignancies

  • Published:5. Mar 2013
  • Dashboard:DCs as cancer vaccines. Mature DCs as a tool to sustain minimal residual disease status in malignancies
  • Authors:E. Ioannou, M. Chatziioannou, M. Toloudi, P. Apostolou, I. Papasotiriou

Read article

Find out more about the scientific basis of RGCC tests

More information